← Back to Search

Exercise Intervention for Cardiometabolic Health

N/A
Waitlist Available
Led By Jingyi Qian, PhD
Research Sponsored by Brigham and Women's Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up about 12 and 24 hours after exercise
Awards & highlights

Study Summary

This trial seeks to understand how physical activity affects the body's natural clock. Participants will stay in-hospital, exercise, and provide samples.

Who is the study for?
This trial is for healthy adults aged 20-45 with a BMI of 20-34.9, without any serious health issues like heart disease or cancer. Participants must be willing to follow the study's rules, including staying in the hospital and doing moderate exercise.Check my eligibility
What is being tested?
The study aims to see how our body clocks affect physical activity by having participants stay twice in a clinic, do some exercise, eat set meals, and give blood, urine, and saliva samples for testing.See study design
What are the potential side effects?
Since this is an exercise intervention study focusing on healthy individuals without underlying conditions, significant side effects are not expected. However, typical reactions might include muscle soreness or fatigue from the physical activities.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~about 12 and 24 hours after exercise
This trial's timeline: 3 weeks for screening, Varies for treatment, and about 12 and 24 hours after exercise for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
glucose level
mean arterial pressure
Secondary outcome measures
autonomic nervous system activity
beta-cell function index
insulin sensitivity index
+1 more
Other outcome measures
respiratory exchange ratio
resting energy expenditure

Trial Design

2Treatment groups
Experimental Treatment
Group I: Exercise B-A InterventionExperimental Treatment1 Intervention
The Exercise B first, then the Exercise A intervention.
Group II: Exercise A-B InterventionExperimental Treatment1 Intervention
The Exercise A first, then the Exercise B intervention.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Exercise intervention
2015
Completed Phase 4
~2150

Find a Location

Who is running the clinical trial?

Brigham and Women's HospitalLead Sponsor
1,616 Previous Clinical Trials
11,470,922 Total Patients Enrolled
National Heart, Lung, and Blood Institute (NHLBI)NIH
3,840 Previous Clinical Trials
47,852,098 Total Patients Enrolled
Jingyi Qian, PhDPrincipal InvestigatorBrigham and Women's Hospital

Media Library

Exercise intervention Clinical Trial Eligibility Overview. Trial Name: NCT05838508 — N/A
Lifestyle Research Study Groups: Exercise A-B Intervention, Exercise B-A Intervention
Lifestyle Clinical Trial 2023: Exercise intervention Highlights & Side Effects. Trial Name: NCT05838508 — N/A
Exercise intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05838508 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research program permit geriatric individuals to participate?

"The age range for those eligible to partake in this research is 20 through 45 years of age. For younger and elderly patients, there are two separate studies they can be a part of instead."

Answered by AI

What is the underlying purpose of this scientific investigation?

"The central metric evaluated during the 24-hour examination following exercise is glucose concentration. Secondary assessments include a beta-cell function index, total peripheral resistance, and autonomic nervous system activity that are derived from blood pressure readings, insulin levels, c-peptides concentrations, and heart rate variability analysis respectively."

Answered by AI

Would I be eligible to participate in this medical trial?

"To be eligible for enrollment, volunteers must conform to a certain lifestyle and age criteria between 20-45 years old. This clinical study is aiming to have 26 participants in total."

Answered by AI

Are there any remaining slots available in this clinical research endeavor?

"Unfortunately, according to clinicaltrials.gov this trial is not enrolling participants at the moment after being last updated on April 28th 2023. Nevertheless, there are still 26 other ongoing trials recruiting patients as we speak."

Answered by AI
~17 spots leftby Aug 2026